Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [10/30/2025 11:45 PDT] Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), Down By 100% ($1.83) From $1.83 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [10/27/2025 06:48 PDT] RANI Expected to Trade Down After Bearish Patterns Develop
• [10/21/2025 21:21 PDT] Market Maker Surveillance Report. RANI, Winning Stocks With Lowest Price Friction For Tuesday, October 21st 2025
• [10/21/2025 08:17 PDT] Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), Up By 100% ($2.25) From $2.25 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/20/2025 21:22 PDT] Market Maker Surveillance Report. RANI, Bullishly Biased Price Friction For Monday, October 20th 2025
• [10/20/2025 10:29 PDT] Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), Up By 100% ($0.49) From $0.49 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/20/2025 10:29 PDT] Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), Up By 100% ($0.5) From $0.499 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [10/17/2025 21:22 PDT] Market Maker Surveillance Report. RANI, Bullishly Biased Price Friction For Friday, October 17th 2025
• [10/16/2025 07:06 PDT] RANI Expected to Trade Up After Bullish Patterns Develop
• [10/15/2025 13:17 PDT] RANI Expected to Trade Up After Bullish Patterns Develop
• [09/09/2025 07:18 PDT] RANI Expected to Trade Up After Bullish Patterns Develop